|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Insulin sensitizers in treatment of nonalcoholic fatty liver disease:Systematic review显示文摘AIM: To summarize the evidence available for the clinical effectiveness of insulin sensitizers in the treatment of nonalcoholic fatty liver disease (NAFLD) systematically. METHODS: Relevant articles were located using computer-assisted searches of Medline (1966-March 2006), EMBASE (1988-March 2006), CINAHL (1982-March 2003), Educational Resource Information Center (1966-March 2006), Library, Information Science & Technology Abstracts (1967-March 2006), Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects (1994-2006), dissertations in ProQuest and FirstSearch databases. Manual searches were made in the abstracts from meetings of the American Gastroenterological Association (1999-2006), and the American Association for the Study of Liver Diseases (2003-2005). Studies were retrieved using the following selection criteria: (1) clinical trials using insulin sensitizers in subjects with NAFLD, (2) adult patients, (3) published as full manuscripts or abstracts, and (4) English, Spanish, German, and French languages only. Data were abstracted independently by two reviewers following standardized procedures. A face-to- face comparison of data was conducted to ensure the completeness and reliability of the abstraction process. RESULTS: Nine studies were included, six using metformin and three using thiazolidinediones. Only two studies were placebo-controlled trials. The mediansample size for all studies was 18 subjects. In the placebo-controlled trials, metformin improved insulin resistance markers and liver function tests, but not histological scores. In the single-arm trials, metformin and thiazolidinediones improved insulin resistance markers and liver function tests, and beneficial histological changes were reported. There is limited high-quality information available from which to draw categorical conclusions about the clinical use of insulin sensitizers in NAFLD.CONCLUSION: Current information indicates that the use of insulin sensitizers in NAFLD improves insulin resistance and liver function. Histological changes must be corroborated in randomized controlled trials. | Norberto C Chavez-Tapia Tonatiuh Barrientos-Gutierrez Felix I Tellez-ávila Francisco Sánchez-ávila Maria Antonieta Montao-Reyes Misael Uribe | 2006 | World Journal of Gastroenterology2006，12，48： | 11 |
| 2 | Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis via AMPK and mTOR regulation显示文摘BACKGROUND Arachidyl amido cholanoic acid(Aramchol)is a potent downregulator of hepatic stearoyl-CoA desaturase 1(SCD1)protein expression that reduces liver triglycerides and fibrosis in animal models of steatohepatitis.In a phase IIb clinical trial in patients with nonalcoholic steatohepatitis(NASH),52 wk of treatment with Aramchol reduced blood levels of glycated hemoglobin A1c,an indicator of glycemic control.AIM To assess lipid and glucose metabolism in mouse hepatocytes and in a NASH mouse model[induced with a 0.1%methionine and choline deficient diet(0.1MCD)]after treatment with Aramchol.METHODS Isolated primary mouse hepatocytes were incubated with 20μmol/L Aramchol or vehicle for 48 h.Subsequently,analyses were performed including Western blot,proteomics by mass spectrometry,and fluxomic analysis with 13C-uniformly labeled glucose.For the in vivo part of the study,male C57BL/6J mice were randomly fed a control or 0.1MCD for 4 wk and received 1 or 5 mg/kg/d Aramchol or vehicle by intragastric gavage for the last 2 wk.Liver metabolomics were assessed using ultra-high-performance liquid chromatography-time of flight-MS for the determination of glucose metabolism-related metabolites.RESULTS Combination of proteomics and Western blot analyses showed increased AMPK activity while the activity of nutrient sensor mTORC1 was decreased by Aramchol in hepatocytes.This translated into changes in the content of their downstream targets including proteins involved in fatty acid(FA)synthesis and oxidation[PACCα/β(S79),SCD1,CPT1A/B,HADHA,and HADHB],oxidative phosphorylation(NDUFA9,NDUFB11,NDUFS1,NDUFV1,ETFDH,and UQCRC2),tricarboxylic acid(TCA)cycle(MDH2,SUCLA2,and SUCLG2),and ribosome(P-p70S6K[T389]and P-S6[S235/S236]).Flux experiments with 13Cuniformely labeled glucose showed that TCA cycle cataplerosis was reduced by Aramchol in hepatocytes,as indicated by the increase in the number of rounds that malate remained in the TCA cycle.Finally,liver metabolomic analysis showed that glucose homeostasis was improved by Aramchol in 0.1MCD fed mice in a dose-dependent manner,showing normalization of glucose,G6P,F6P,UDP-glucose,and Rbl5P/Xyl5P.CONCLUSION Aramchol exerts its effect on glucose and lipid metabolism in NASH through activation of AMPK and inhibition of mTORC1,which in turn activate FAβ-oxidation and oxidative phosphorylation. | David Fernández-Ramos Fernando Lopitz-Otsoa Laura Delacruz-Villar Jon Bilbao Martina Pagano Laura Mosca Maider Bizkarguenaga Marina Serrano-Macia Mikel Azkargorta Marta Iruarrizaga-Lejarreta Jesús Sot Darya Tsvirkun Sebastiaan Martijn van Liempd Felix M Goni Cristina Alonso María Luz Martínez-Chantar Felix Elortza Liat Hayardeny Shelly C Lu JoséM Mato | 2020 | World Journal of Gastroenterology2020，26，34： | 5 |
| 3 | Clinical implications of diabetes in chronic liver disease:Diagnosis,outcomes and management,current and future perspectives显示文摘Diabetes mellitus(DM)is common in liver cirrhosis(LC).The pathophysiological association is bidirectional.DM is a risk factor of LC and LC is a diabetogenic condition.In the recent years,research on different aspects of the association DM and LC has been intensified.Nevertheless,it has been insufficient and still exist many gaps.The aims of this review are:(1)To discuss the latest understandings of the association of DM and LC in order to identify the strategies of early diagnosis;(2)To evaluate the impact of DM on outcomes of LC patients;and(3)To select the most adequate management benefiting the two conditions.Literature searches were conducted using Pub Med,Ovid and Scopus engines for DM and LC,diagnosis,outcomes and management.The authors also provided insight from their own published experience.Based on the published studies,two types of DM associated with LC have emerged:Type 2 DM(T2 DM)and hepatogenous diabetes(HD).High-quality evidences have determined that T2 DM or HD significantly increase complications and death pre and post-liver transplantation.HD has been poorly studied and has not been recognized as a complication of LC.The management of DM in LC patients continues to be difficult and should be based on drug pharmacokinetics and the degree of liver failure.In conclusion,the clinical impact of DM in outcomes of LC patients has been the most studied item recently.Nevertheless many gaps still exist particularly in the management.These most important gaps were highlighted in order to propose future lines for research. | Diego García-Compeán Emanuela Orsi Ramesh Kumar Felix Gundling Tsutomu Nishida Jesús Zacarías Villarreal-Pérez Ángel N Del Cueto-Aguilera JoséA González-González Giuseppe Pugliese | 2022 | World Journal of Gastroenterology2022，28，8： | 4 |
| 4 | 成人IDH野生型星形细胞瘤从生物学和临床上归为其他肿瘤类型显示文摘WHO III级的IDH野生型间变性星形细胞瘤预后差。为了对星形细胞瘤进行分子亚组分型或诊断上的重新分类,作者分析160例成人IDH野生型星形细胞肿瘤的分子标志性变异,并行甲基化和拷贝数分析,其中包括120例 WHO III级的间变性星形细胞瘤和40例WHO II级的弥漫型星形细胞瘤。基于分子谱系和标志性变异特征,将这些肿瘤分为四个主要亚型。78%肿瘤诊断为传统胶质母细胞瘤分子亚型。9%为GBM-H3F3A突变(GBM-H3)亚型。8%具有独特的甲基化特征,与GBM-H3-K27相似,但缺乏H3F3A突变,这组肿瘤主要发生在幕下及中线部位,并且预后较好。120例IDH野生型的间变性星形细胞瘤除1例外均可归入上述3种亚型中。40例WHO II级的弥漫型星形细胞瘤中7例具有不同的分子特征,其中6例重新归类为其他不同的低级别肿瘤类型。有趣的是,TERT突变只发生在分子亚型的GBM (78%),且预后不良。 GBM-H3组缺乏 TERT突变,然而其预后更差。 | David E R Annekathrin K Felix S 李晓玲 王行富 | 2015 | 临床与实验病理学杂志2015，31，9： | 4 |
| 5 | Immunological aspects of liver cell transplantation显示文摘Within the field of regenerative medicine, the liver is of major interest for adoption of regenerative strategies due to its well-known and unique regenerative capacity. Whereas therapeutic strategies such as liver resection and orthotopic liver transplantation(OLT) can be considered standards of care for the treatment of a variety of liver diseases, the concept of liver cell transplantation(LCTx) still awaits clinical breakthrough. Success of LCTx is hampered by insufficient engraftment/long-term acceptance of cellular allografts mainly due to rejection of transplanted cells. This is in contrast to the results achieved for OLT where longterm graft survival is observed on a regular basis and, hence, the liver has been deemed an immuneprivileged organ. Immune responses induced by isolated hepatocytes apparently differ considerably from those observed following transplantation of solid organs and, thus, LCTx requires refined immunological strategies to improve its clinical outcome. In addition, clinical usage of LCTx but also related basic research efforts are hindered by the limited availability of high quality liver cells, strongly emphasizing the need for alternative cell sources. This review focuses on the various immunological aspects of LCTx summarizing data available not only for hepatocyte transplantation but also for transplantation of non-parenchymal liver cells and liver stem cells. | Felix Oldhafer Michael Bock Christine S Falk Florian WR Vondran | 2016 | World Journal of Transplantation2016，6，1： | 3 |
| 6 | First Pre‐Functionalised Polymeric Aromatic Framework from Mononitrotetrakis(iodophenyl)methane and its Applications显示文摘 | Ester Verde‐Sesto Mercedes Pintado‐Sierra Avelino Corma Eva M. Maya Jose G. de la Campa Marta Iglesias Felix Sánchez | 2014 | Chem. Eur. J2014，，17： | 2 |
| 7 | Novel p19 Protein Engages IL-12p40 to Form a Cytokine, IL-23, with Biological Activities Similar as Well as Distinct from IL-12显示文摘 | Birgit Oppmann Robin Lesley Bianca Blom Jackie C Timans Yuming Xu Brisdell Hunte Felix Vega Nancy Yu Jing Wang Komal Singh Francesca Zonin Elena Vaisberg Tatyana Churakova Man-ru Liu Daniel Gorman Janet Wagner Sandra Zurawski Yong-Jun Liu John S Abrams Ke | 2000 | Immunity2000，，5： | 2 |
| 8 | The antagonism of glueoeortieoid inhibition of wound healing in rats by growth hormone-releasing factor显示文摘 | Kelley S F Felix A M Ehrlieh H P | 1990 | Proe Soe Exp Biol Med1990，194，4： | 1 |
| 9 | Plants have a sensitive perception system for the most conserved domain of bacterial flagellin 显示文摘 | FELIX G DURAN JD VOLKO S | 1999 | The Plant Journal1999，18，3： | 1 |
| 10 | Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial显示文摘 | Benjamin M Scirica Marc P Bonaca Eugene Braunwald Gaetano M De Ferrari Daniel Isaza Basil S Lewis Felix Mehrhof Piera A Merlini Sabina A Murphy Marc S Sabatine Michal Tendera Frans Van de Werf Robert Wilcox David A Morrow | 2012 | The Lancet . 2012 (9850)2012，，9850： | 1 |
| 11 | Latent heat thermal energy storage using cylindrical capsule: Numerical and experimental investigations 显示文摘 | A Felix Regin S C Solanki J S Saini | 2006 | Renewable Energy2006，31，13： | 1 |
| 12 | The effect of formal instruction on second language acquisition显示文摘 | | 1981 | (31):87-1121981，，31： | 1 |
| 13 | Global Supplier Selection: A Fuzzy-AHP Approach显示文摘 | Felix T S C Kumar N Tiwari M K | 2008 | International Journal ofProductionResearch2008，46，14： | 1 |
| 14 | E - selectin polymorphism and atherosclerosis : an association study显示文摘 | Wenzel K Felix S Kleber FX | 1994 | Hum Mol Genet1994，3，： | 1 |
| 15 | The two patterns of reactive astrocytosis in postischemic rat brain显示文摘 | Petito CK Morgello S Felix LC | 1990 | J Cereb Blood Flow Metab1990，10，： | 1 |
| 16 | The successful treatment of lupus pemio with the flashlamp pulsed dye laser 显示文摘 | Cliff S Felix RH Singh L | 1999 | J Cutan Laser Ther1999，1，1： | 1 |
| 17 | Studies on energetic compounds part 36 :Evaluation of transition metal salts of NTO as burning rate modifiers for HTPB-AN composite solid propellants显示文摘 | Singh G Felix S P | 2003 | Combustion and Flame2003，135，： | 1 |
| 18 | Laparoscopic hemioplasty:signifieant complications 显示文摘 | Felix E Habertson N Varteian S | 1999 | Surg Endosc1999，13，1： | 1 |
| 19 | Expression of metastases-associated genes in cervical cancers resected in proliferative and secretory phases of the menstrual cycle显示文摘 | Formenti S Felix J Salonga D | 2000 | Clin Cancer Res2000，6，12： | 1 |
| 20 | Fuzzy constraint networks for signal pattern recognition 显示文摘 | Felix P Barro S Maryyn R | 2003 | Artificial Intelligence Special Issue on Fuzzy Logic2003，148，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员